Browsing by Author "Escalona, Alex"

Now showing 1 - 16 of 16
  • Thumbnail Image
    Item
    Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients
    (2014) Muñoz, R.; Domínguez de Landa, María Angélica; Muñoz, F.; Muñoz, C.; Slako, M.; Turiel, D.; Pimentel Muller, Fernando; Sharp Pittet, Allan Carlos; Escalona, Alex
  • Thumbnail Image
    Item
    Bile acids synthesis decreases after laparoscopic sleeve gastrectomy
    (2016) Escalona, Alex; Muñoz, R.; Irribarra Pastenes, Verónica; Solari Gajardo, Sandra; Allende, Fidel; Miquel P., Juan Francisco
  • Thumbnail Image
    Item
    Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients
    (2017) Medina, D. A.; Pedreros, J. P.; Turiel, D.; Quezada Sanhueza, Nicolás; Pimentel Muller, Fernando; Escalona, Alex; Garrido Cortés, Daniel
  • Thumbnail Image
    Item
  • Thumbnail Image
    Item
    Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial
    (2015) Kappelle, W.; Bredenoord, A.; Conchillo, J.; Ruurda, J.; Bouvy, N.; Henegouwen, M.; Chiu, P.; Booth, M.; Hani, A.; Escalona, Alex; Reddy, D.; Bogte, A.; Smout, A.; Wu, J.; Valdovinos, M.; Torres, G.; Siersema, P.
  • Thumbnail Image
    Item
    Gastrectomía laparoscópica en cáncer gástrico: Experiencia preliminar
    (2007) Escalona, Alex; Pérez Blanco, Gustavo Adolfo; Crovari Eulufi, Fernando; Boza, Camilo; Pimentel Muller, Fernando; Devauda, Nicolás; Guzmán Karadima, Sergio; Ibáñez Anrique, Luis
    Background: The development of the laparoscopic surgery has allowed its incorporation to the surgical treatment of gastric cancer. Aim: To evaluate the feasibility and safety of laparoscopic gastrectomy in gastric cancer in our institution. Patients and methods: Prospective data in four patients who underwent laparoscopic gastrectomy for gastric cancer from May to August of 2005 was reviewed. Demographic data, clinical characteristics and postoperative results were registered. Patients were staged according to TNM-AJJC staging system. Results: Four patients aged 48 to 80 years (three males), underwent a completely laparoscopic R0 gastrectomy with lymph node dissection. Two patients underwent total gastrectomy. A subtotal Billroth II gastrectomy was performed in the other two patients. The mean operative time was 260 minutes (Range 180-330). There were no conversions to open surgery. The mean postoperative hospital stay was 6.5 days (Range 6-7 days). There were no complications. According to pathology, one patient presented carcinoma in stage IA, two patients in stage IB and one patient in stage IIIB. The mean number of lymph nodes dissected was 40 (Range 35-54). Conclusions: Laparoscopic gastrectomy is a feasible procedure with good postoperative results in this preliminary experience.
  • Thumbnail Image
    Item
    High Frequency of Internal Hernias After Roux-en-Y Gastric Bypass
    (2015) Quezada Sanhueza, Nicolás; León, Felipe; Jones, Alex; Varas, Julián; Funke, Ricardo; Crovari Eulufi, Fernando; Raddatz Echavarría, Alejandro; Pérez Blanco, Gustavo Adolfo; Escalona, Alex; Boza, Camilo; Quezada Sanhueza, Nicolás; León, Felipe; Jones, Alex; Varas, Julián; Funke, Ricardo; Crovari Eulufi, Fernando; Raddatz, Alejandro; Pérez Blanco, Gustavo Adolfo; Escalona, Alex; Boza, Camilo
  • Thumbnail Image
    Item
    Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up
    (ELSEVIER SCIENCE INC, 2010) Boza, Camilo; Gamboa, Cristian; Awruch, Diego; Perez, Gustavo; Escalona, Alex; Ibanez, Luis
    Background: Bariatric surgery is an effective treatment for morbid obesity Laparoscopic Rouxen-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) are commonly performed procedures The aim of the present study was to evaluate and compare the lone-term outcomes after LRYGB and LAGB
  • Thumbnail Image
    Item
    Necrosectomía laparoscópica en pancreatitis aguda
    (2010) Funke, Ricardo; Donoso, A.; Rondanelli, M. O.; Patillo, J. C.; Boza, Camilo; Crovari Eulufi, Fernando; Perez, G.; Pimentel Muller, Fernando; Ibañez Anrique, Luis; Guzmán Karadima, Sergio; Jarufe Cassis, Nicolás; Escalona, Alex; Funke, R.; Donoso, A.; Rondanelli, M. O.; Patillo, J. C.; Boza, Camilo; Crovari Eulufi, Fernando; Perez, G.; Pimentel Muller, Fernando; Ibañez Anrique, Luis; Guzman, S.; Jarufe Cassis, Nicolás; Escalona, A.
    Introducción: La pancreatitis aguda grave, asociada a necrosis pancreática infectada, tiene una elevada mortalidad. En la mayoría de los casos, el tratamiento es quirúrgico, sin embargo, este se asocia a una alta morbilidad. El desarrollo de la cirugía mí
  • Thumbnail Image
    Item
    Overexpression of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
    (SPRINGER, 2010) Baudrand, Rene; Carvajal, Cristian A.; Riquelme, Arnoldo; Morales, Mauricio; Solis, Nancy; Pizarro, Margarita; Escalona, Alex; Boza, Camilo; Perez, Gustavo; Dominguez, Angelica; Arrese, Marco; Fardella, Carlos E.
    The enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyzes intracellular glucocorticoid reactivation by conversion of cortisone to cortisol in different tissues and have been implicated in several metabolic disorders associated with obesity. The aim of this study was to evaluate the 11 beta-HSD1 expression in liver, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) in morbidly obese patients undergoing bariatric surgery and its correlations with clinical, anthropometric, and biochemical variables.
  • Thumbnail Image
    Item
    Overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease
    (WILEY, 2012) Candia, Roberto; Riquelme, Arnoldo; Baudrand, Rene; Carvajal, Cristian A.; Morales, Mauricio; Solis, Nancy; Pizarro, Margarita; Escalona, Alex; Carrasco, Gonzalo; Boza, Camilo; Perez, Gustavo; Padilla, Oslando; Cerda, Jaime; Fardella, Carlos E.; Arrese, Marco
    Background: The enzyme 11 beta-hydroxysteroid-dehydrogenase type 1 (11 beta HSD1) catalyses the reactivation of intracellular cortisol. We explored the potential role of 11 beta-HSD1 overexpression in visceral adipose tissue (VAT) in non-alcoholic fatty liver disease (NAFLD) assessing sequential changes of enzyme expression, in hepatic and adipose tissue, and the occurrence of portal hypercortisolism in obese mice. 11 beta-HSD1 expression was also assessed in tissues from obese patients undergoing bariatric surgery. Methods: Peripheral and portal corticosterone levels and liver histology were assessed in ob/ob mice at two time points (8-12 weeks of age). 11 beta-HSD1 tissue expression was assessed in by RT-pcr in ob/ob mice and in 49 morbidly obese patients. Results: Portal corticosterone serum levels were higher in obese mice with a 26% decrease between 8 and 12 weeks of age (controls: 78.3 +/- 19.7 ng/ml, 8-week-old ob/ob: 167.5 +/- 14.5 ng/ml and 12-week-old ob/ob: 124.3 +/- 28 ng/ml, P < 0.05). No significant differences were found in peripheral corticosterone serum levels. Expression of 11b-HSD1 was lower in the liver [-45% at 8 weeks and -35% at 12-weeks (P = 0.0001)] and highly overexpressed in VAT in obese mice, compared to controls (128-fold higher in 8-week-old ob/ob and 41-fold higher in 12-week-old ob/ob, P < 0.01). No significant differences were seen in the expression of 11 beta-HSD1 in subcutaneous adipose tissue. In multivariate analysis, human 11 beta-HSD1 expression in VAT (OR: 1.385 +/- 1.010-1.910) was associated with NAFLD. Conclusion: Murine NAFLD is associated with portal hypercortisolism and 11 beta-HSD1 overexpression in VAT. In humans, 11 beta-HSD1 VAT expression was associated with the presence of NAFLD. Thus, local corticosteroid production in VAT may contribute to NAFLD pathogenesis.
  • No Thumbnail Available
    Item
    Overexpression of hepatic 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients
    (W B SAUNDERS CO-ELSEVIER INC, 2011) Baudrand Biggs Rene Felipe; Domínguez Ruiz-tagle, José Miguel; Carvajal, Cristian A.; Riquelme, Arnoldo; Campino, Carmen; Macchiavello, Stefano; Bozinovic, Milan; Morales, Mauricio; Pizarro, Margarita; Solis, Nancy; Escalona, Alex; Boza, Camilo; Arrese, Marco; Fardella, Carlos E.
    11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) converts cortisone to cortisol, mainly in the liver and visceral adipose tissue (VAT), and has been implicated in several metabolic disorders. The absence of systemic hypercortisolism in central obesity could be due to increased inactivation of cortisol to its tetrahydrometabolites by the hepatic enzymes 5 alpha-and 5 beta-reductases. Our aim was to assess the expression of the reductases in the liver and of 11 beta-HSD1 in the liver and VAT in morbidly obese patients and to analyze their association with clinical, anthropometric, and biochemical parameters. Hepatic and VAT samples were obtained during bariatric surgery. 5 alpha- and 5 beta-reductases, 11 beta-HSD1, and 18S expression was measured using real-time polymerase chain reaction. Anthropometric and biochemical variables were analyzed. Forty-one patients were recruited (age, 41.8 +/- 10.6 years; body mass index, 42.1 +/- 6.6 kg/m(2); 71% women). The expression of hepatic 5 alpha- and 5 beta-reductases was positively correlated (r = +0.53, P = .004), and their expression levels were correlated with hepatic 11 beta-HSD1 expression (r = +0.61, P < .001 for 5 alpha-reductase and r = +0.50, P < .001 for 5 beta-reductase). Hepatic 5 alpha-reductase was associated with insulin (r = +0.34, P = .015). Visceral adipose tissue 11 beta-HSD1 expression was associated with glucose (r = +0.37, P = .025) and insulin (r = +0.54, P = .002). Our results showed that 5 alpha-reductase and VAT 11 beta-HSD1 expressions were associated with insulinemia. These findings suggest that overexpression of 5 alpha-reductase, through a higher inactivation of cortisol in the liver, could have a protective role in preserving hepatic sensitivity to insulin. The overexpression of liver reductases in obesity could be an adaptive response to an increase in cortisol production by the liver and visceral 11 beta-HSD1 to avoid systemic hypercortisolism. (C) 2011 Elsevier Inc. All rights reserved.
  • Thumbnail Image
    Item
    Prevención de la recurrencia peritoneal en el tratamiento quirúrgico del cáncer gástrico
    (2014) Ceroni Villanelo, Marco; Viñuela Fawaz, Eduardo Andrés; Norero Muñoz, Enrique; Jarufe Cassis, Nicolás; Crovari Eulufi, Fernando; Escalona, Alex; Sharp Pittet, Allan Carlos; Briceño, Eduardo; Martínez Belmar, Cristian Antonio; Díaz Fernández, Alfonso; Ibáñez Anrique, Luis
  • Thumbnail Image
    Item
    Safety and efficacy of the endoscopic duodenal–jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years
    (2018) Quezada Sanhueza, Nicolás; Muñoz Claro, Rodrigo Edgardo; Morelli, Carla; Turiel, Dannae; Hernández, Julián; Pimentel Muller, Fernando; Escalona, Alex
  • Thumbnail Image
    Item
    Úlcera marginal perforada post bypass gástrico laparoscópico
    (2015) Marambio Granic, Andrés Javier; Gabrielli Nervi, Mauricio; De la Llera K., Juan Francisco; Crovari Eulufi, Fernando; Pérez Blanco, Gustavo Adolfo; Ibáñez Anrique, Luis; Funke, Ricardo; Pimentel Muller, Fernando; Escalona, Alex; Norero Muñoz, Enrique; Boza, Camilo; Marambio Granic, Andrés Javier; Gabrielli Nervi, Mauricio; De la Llera K., Juan Francisco; Crovari Eulufi, Fernando; Pérez Blanco, Gustavo Adolfo; Ibáñez Anrique, Luis; Funke H., Ricardo; Pimentel Muller, Fernando; Escalona P., Alex; Norero Muñoz, Enrique; Boza, Camilo
  • Thumbnail Image
    Item
    Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner
    (LIPPINCOTT WILLIAMS & WILKINS, 2012) Escalona, Alex; Pimentel, Fernando; Sharp, Allan; Becerra, Pablo; Slako, Milenko; Turiel, Dannae; Munoz, Rodrigo; Bambs, Claudia; Guzman, Sergio; Ibanez, Luis; Gersin, Keith
    Objective: To evaluate safety, weight loss, and cardiometabolic changes in obese subjects implanted with the duodenal-jejunal bypass liner (DJBL) for 1 year.